Medication Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medication stocks.

Medication Stocks Recent News

Date Stock Title
Nov 21 MRK Top Analyst Reports for Broadcom, Merck & Qualcomm
Nov 21 MRK Optimism over global healthcare sector rises: Jefferies
Nov 21 MRK Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference
Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
Nov 21 NVS Novartis raises mid-term sales guidance
Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
Nov 21 MRK Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
Nov 21 MRK Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals
Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Nov 20 CALC CalciMedica Announces Presentations at Upcoming Medical Meetings
Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
Nov 19 MRK Merck readies new Keytruda version ahead of major regulatory headwinds
Nov 19 MRK Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
Nov 19 MRK Merck raises dividend to $0.81/share
Nov 19 MRK Merck Announces First-Quarter 2025 Dividend
Nov 19 MRK Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
Medication

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags